AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11856590 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy in inflammatory breast cancer
Number of subjects: 0
Study 11856590 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy after conventional treatment
Number of subjects: 0
Study 11856590 — intervention group
Group type: EXPERIMENTAL
Intervention: Evaluation of high-dose chemotherapy strategy
Number of subjects: 0
Study 10205193 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine (15 microg/kg bolus, 4 microg/kg/h infusion)
Number of subjects: 10
Study 10205193 — intervention group
Group type: EXPERIMENTAL
Intervention: Methscopolamine bromide (MSB) (5 mg orally, four times daily for three days)
Number of subjects: 10
Study 10205193 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 10
Study 7594028 — intervention group
Group type: EXPERIMENTAL
Intervention: Arbutamine echocardiography
Number of subjects: 143
Study 7594028 — intervention group
Group type: COMPARATOR
Intervention: Exercise echocardiography
Number of subjects: 143
Study 2528386 — intervention group
Group type: COMPARATOR
Intervention: OK‐432
Number of subjects: 382
Study 2528386 — intervention group
Group type: COMPARATOR
Intervention: sizofiran
Number of subjects: 382
Study 2528386 — intervention group
Group type: COMPARATOR
Intervention: Control (no specific intervention mentioned)
Number of subjects: 382
Study 31821151 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based unguided self-help intervention based on cognitive behavioral principles
Number of subjects: 2116
Study 31821151 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 2116
Study 30024447 — intervention group
Group type: EXPERIMENTAL
Intervention: Brace group (rigid brace full-time for 12 weeks)
Number of subjects: 90
Study 30024447 — intervention group
Group type: COMPARATOR
Intervention: No brace group (soft corset for 2 weeks, then weaned off)
Number of subjects: 90
Study 30024447 — intervention group
Group type: EXPERIMENTAL
Intervention: Brace group
Number of subjects: 90
Study 30024447 — intervention group
Group type: COMPARATOR
Intervention: No brace group
Number of subjects: 90
Study 28017524 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 μg paricalcitol (PCT)/day for 12 weeks
Number of subjects: 88
Study 28017524 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 88
Study 28017524 — intervention group
Group type: EXPERIMENTAL
Intervention: PCT treatment
Number of subjects: 88
Study 26780394 — intervention group
Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (100 mg per day)
Number of subjects: 60
Study 26780394 — intervention group
Group type: COMPARATOR
Intervention: Placebo (100 mg lactose)
Number of subjects: 60
Study 23171573 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g tannin-rich fiber (low-dose group, n = 13)
Number of subjects: 40
Study 23171573 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 g tannin-rich fiber (high-dose group, n = 13)
Number of subjects: 40
Study 23171573 — intervention group
Group type: COMPARATOR
Intervention: 0 g (placebo group, n = 14)
Number of subjects: 40
Study 21365166 — intervention group
Group type: COMPARATOR
Intervention: Program 1 (educational program)
Number of subjects: 4249
Study 21365166 — intervention group
Group type: COMPARATOR
Intervention: Program 2 (active program)
Number of subjects: 4249
Study 19034098 — intervention group
Group type: EXPERIMENTAL
Intervention: Order pattern analysis parameters (permutation entropy, recurrence rate, phase coupling)
Number of subjects: 2
Study 17047607 — intervention group
Group type: EXPERIMENTAL
Intervention: Metrogil-denta with 25% metronidazole concentration
Number of subjects: 76
Study 17047607 — intervention group
Group type: COMPARATOR
Intervention: Metrogil-denta with 1% metronidazole concentration
Number of subjects: 76
Study 12916293 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate
Number of subjects: 0
Study 12916293 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate
Number of subjects: 0
Study 12916293 — intervention group
Group type: COMPARATOR
Intervention: Alendronate and Risedronate
Number of subjects: 0
Study 12916293 — intervention group
Group type: COMPARATOR
Intervention: Combination of bisphosphonates with estrogen or raloxifene
Number of subjects: 0
Study 10960393 — intervention group
Group type: EXPERIMENTAL
Intervention: Nerve stimulation (Group PNS)
Number of subjects: 100
Study 10960393 — intervention group
Group type: COMPARATOR
Intervention: Paresthesia elicitation (Group PAR)
Number of subjects: 100
Study 8968661 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg micronized 17 beta-estradiol and 0.150 mg desogestrel for 21 days followed by 0.030 mg desogestrel for 7 days
Number of subjects: 29
Study 8968661 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 1601378 — intervention group
Group type: EXPERIMENTAL
Intervention: Causal pharmacological treatment of disordered spermatogenesis
Number of subjects: 0
Study 1601378 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical and microsurgical procedures
Number of subjects: 0
Study 1601378 — intervention group
Group type: EXPERIMENTAL
Intervention: Medicinal treatment for disturbances affecting the epididymis and other adnexa
Number of subjects: 0
Study 6437092 — intervention group
Group type: EXPERIMENTAL
Intervention: TTS‐Nitroglycerin
Number of subjects: 12
Study 6437092 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 12
Study 28901214 — intervention group
Group type: EXPERIMENTAL
Intervention: Total dose infusion (TDI) of low molecular weight (LMW) iron dextran
Number of subjects: 66
Study 28901214 — intervention group
Group type: COMPARATOR
Intervention: Oral iron ferrous fumarate 60 mg elemental iron three times daily
Number of subjects: 66
Study 30660136 — intervention group
Group type: COMPARATOR
Intervention: LSM and corn oil (1.5 g/day; placebo)
Number of subjects: 34
Study 30660136 — intervention group
Group type: EXPERIMENTAL
Intervention: LSM & n‐3 (EPA + DHA concentrate 1.5 g/day, containing 0.6 g EPA + DHA)
Number of subjects: 34
Study 30660136 — intervention group
Group type: COMPARATOR
Intervention: LSM
Number of subjects: 34
Study 30660136 — intervention group
Group type: EXPERIMENTAL
Intervention: LSM & n‐3
Number of subjects: 34
Study 26360140 — intervention group
Group type: EXPERIMENTAL
Intervention: Right lateral jack-knife position (RLJK) for 60 minutes
Number of subjects: 50
Study 26360140 — intervention group
Group type: COMPARATOR
Intervention: Right lateral decubitus position (RLD) for 60 minutes
Number of subjects: 50
Study 24685971 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan 85/naproxen sodium 500
Number of subjects: 0
Study 24685971 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 22444781 — intervention group
Group type: EXPERIMENTAL
Intervention: Copper supplementation (2 mg copper/day as copper glycinate) for 8 weeks
Number of subjects: 100
Study 22444781 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 20176277 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic sinus surgery (ESS)
Number of subjects: 28
Study 17571965 — intervention group
Group type: EXPERIMENTAL
Intervention: Very low-fat vegan diet supplemented with soy protein (58 g/day)
Number of subjects: 0
Study 17571965 — intervention group
Group type: COMPARATOR
Intervention: Usual-care controls
Number of subjects: 0
Study 15709054 — intervention group
Group type: EXPERIMENTAL
Intervention: Differential path-length spectroscopy (DPS)
Number of subjects: 64
Study 15709054 — intervention group
Group type: COMPARATOR
Intervention: Normal mucosa
Number of subjects: 64
Study 12224093 — intervention group
Group type: EXPERIMENTAL
Intervention: KTP (532 nm) laser treatment
Number of subjects: 70
Study 10223495 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolterodine 0.5 mg twice daily
Number of subjects: 319
Study 10223495 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolterodine 1 mg twice daily
Number of subjects: 319
Study 10223495 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolterodine 2 mg twice daily
Number of subjects: 319
Study 10223495 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolterodine 4 mg twice daily
Number of subjects: 319
Study 10223495 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 319
Study 7799029 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutathione (GSH) at a dose of 1.5 g/m2 in 100 mL of normal saline solution over a 15‐minute period immediately before CDDP administration, and at a dose of 600 mg by intramuscular injection on days 2 to 5.
Number of subjects: 50
Study 7799029 — intervention group
Group type: COMPARATOR
Intervention: Normal saline solution (placebo).
Number of subjects: 50
Study 7799029 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutathione (GSH).
Number of subjects: 50
Study 2325000 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory aids (MA: n = 36)
Number of subjects: 71
Study 2325000 — intervention group
Group type: COMPARATOR
Intervention: No memory aids (NMA: n = 35)
Number of subjects: 71
Study 391050 — intervention group
Group type: EXPERIMENTAL
Intervention: Polycon lenses
Number of subjects: 5
Study 391050 — intervention group
Group type: COMPARATOR
Intervention: PMMA lenses
Number of subjects: 5
Study 391050 — intervention group
Group type: COMPARATOR
Intervention: BP Flex lenses
Number of subjects: 5
Study 391050 — intervention group
Group type: EXPERIMENTAL
Intervention: Steeper‐fitting PMMA lenses
Number of subjects: 5
Study 391050 — intervention group
Group type: EXPERIMENTAL
Intervention: Steeper‐fitting BP Flex lenses
Number of subjects: 5
Study 391050 — intervention group
Group type: EXPERIMENTAL
Intervention: Steeper‐fitting Polycon lenses
Number of subjects: 5
Study 31347411 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education intervention for caregivers, including a health education booklet and individual explanation
Number of subjects: 177
Study 31347411 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education intervention for caregivers
Number of subjects: 177
Study 30946273 — intervention group
Group type: EXPERIMENTAL
Intervention: Football prediction equation for V[Combining Dot Above]O2max using treadmill exercise time (Tmin)
Number of subjects: 472
Study 30946273 — intervention group
Group type: COMPARATOR
Intervention: Foster prediction equation for V[Combining Dot Above]O2max
Number of subjects: 472
Study 30946273 — intervention group
Group type: COMPARATOR
Intervention: Bruce prediction equation for V[Combining Dot Above]O2max
Number of subjects: 472
Study 30946273 — intervention group
Group type: EXPERIMENTAL
Intervention: Football prediction equation for V[Combining Dot Above]O2max
Number of subjects: 472
Study 27943425 — intervention group
Group type: EXPERIMENTAL
Intervention: Acitretin
Number of subjects: 289
Study 27943425 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate
Number of subjects: 289
Study 27943425 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporin
Number of subjects: 289
Study 26834282 — intervention group
Group type: EXPERIMENTAL
Intervention: Pumpless group (PL group: blood cardioplegia administration without roller pump)
Number of subjects: 68
Study 26834282 — intervention group
Group type: COMPARATOR
Intervention: Roller pump group (RP group: blood cardioplegia administration with roller pump)
Number of subjects: 68
Study 26834282 — intervention group
Group type: EXPERIMENTAL
Intervention: Pumpless group (PL group)
Number of subjects: 68
Study 26834282 — intervention group
Group type: COMPARATOR
Intervention: Roller pump group (RP group)
Number of subjects: 68
Study 24392604 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle Self-Efficacy Scale for Latinos with Diabetes (LSESLD)
Number of subjects: 252
Study 20811299 — intervention group
Group type: EXPERIMENTAL
Intervention: Myo-inositol (2 g BID plus diet)
Number of subjects: 80
Study 20811299 — intervention group
Group type: COMPARATOR
Intervention: Placebo (diet plus placebo)
Number of subjects: 80
Study 19356420 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast agent use during dobutamine stress echocardiography (DSE)
Number of subjects: 101
Study 16237629 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing instruction
Number of subjects: 0
Study 11875694 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratumoural/intrapleural SRL172 (1 microg to 1 mg) and intradermal SRL172 (1 mg) with standard chemotherapy (mitomycin‐C: 8 mg m(‐2), vinblastine: 6 mg m(‐2), cisplatin: 50 mg m(‐2))
Number of subjects: 16
Study 11875694 — intervention group
Group type: COMPARATOR
Intervention: Standard chemotherapy (mitomycin‐C, vinblastine, cisplatin)
Number of subjects: 16
Study 10445196 — intervention group
Group type: EXPERIMENTAL
Intervention: ketorolac tromethamine
Number of subjects: 97
Study 10445196 — intervention group
Group type: EXPERIMENTAL
Intervention: diclofenac sodium
Number of subjects: 97
Study 10445196 — intervention group
Group type: COMPARATOR
Intervention: moist drops (control)
Number of subjects: 97
Study 8636518 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure Support Ventilation (PSb)
Number of subjects: 10
Study 8636518 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure Support Ventilation (PSb + 5)
Number of subjects: 10
Study 8636518 — intervention group
Group type: EXPERIMENTAL
Intervention: External PEEP (PEEPe) of 75% of static intrinsic PEEP during PSb
Number of subjects: 10
Study 2276936 — intervention group
Group type: EXPERIMENTAL
Intervention: Inflatable constricting device applied to the proximal aspect of the arm, inflated to 80 mm Hg
Number of subjects: 0
Study 2276936 — intervention group
Group type: EXPERIMENTAL
Intervention: Inflatable constricting device applied to the proximal aspect of the arm, inflated to 100 mm Hg
Number of subjects: 0
Study 2276936 — intervention group
Group type: EXPERIMENTAL
Intervention: Inflatable constricting device applied to the proximal aspect of the arm, inflated to 20 mm Hg
Number of subjects: 0
Study 117492 — intervention group
Group type: EXPERIMENTAL
Intervention: Deanol acetamidobenzoate, administered in doses up to 1.5 g q.d. for three weeks
Number of subjects: 0
Study 117492 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30477998 — intervention group
Group type: EXPERIMENTAL
Intervention: Companion present during neuraxial catheter placement
Number of subjects: 143
Study 30477998 — intervention group
Group type: COMPARATOR
Intervention: Companion not present during neuraxial catheter placement
Number of subjects: 143
Study 30477998 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (companion present and not present)
Number of subjects: 143
Study 27212001 — intervention group
Group type: EXPERIMENTAL
Intervention: 67% sodium bicarbonate toothpaste
Number of subjects: 148
Study 27212001 — intervention group
Group type: COMPARATOR
Intervention: 0% sodium bicarbonate toothpaste
Number of subjects: 148
Study 26352896 — intervention group
Group type: EXPERIMENTAL
Intervention: sirolimus‐eluting stent
Number of subjects: 170
Study 26352896 — intervention group
Group type: COMPARATOR
Intervention: biolimus‐eluting stent
Number of subjects: 170
Study 23432593 — intervention group
Group type: EXPERIMENTAL
Intervention: MI+HealthCall
Number of subjects: 258
Study 23432593 — intervention group
Group type: EXPERIMENTAL
Intervention: MI-only
Number of subjects: 258
Study 23432593 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 258
Study 20680671 — intervention group
Group type: EXPERIMENTAL
Intervention: Mother and father as caregivers
Number of subjects: 784
Study 20680671 — intervention group
Group type: COMPARATOR
Intervention: Mother and grandparents as caregivers
Number of subjects: 784
Study 18797946 — intervention group
Group type: EXPERIMENTAL
Intervention: Solis cage, Stryker Company
Number of subjects: 60
Study 18797946 — intervention group
Group type: COMPARATOR
Intervention: Shell cage, AMT Company
Number of subjects: 60
Study 18797946 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study 17868841 — intervention group
Group type: EXPERIMENTAL
Intervention: Interscalene block
Number of subjects: 56
Study 17868841 — intervention group
Group type: COMPARATOR
Intervention: Continuous infusion of 0.5% bupivacaine via pain pump for 48 hours
Number of subjects: 56
Study 15328325 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone psychotherapy
Number of subjects: 600
Study 15328325 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone care management
Number of subjects: 600
Study 15328325 — intervention group
Group type: COMPARATOR
Intervention: Usual primary care
Number of subjects: 600
Study 11454528 — intervention group
Group type: EXPERIMENTAL
Intervention: Unfractionated heparin (UFH) - 5,000 IU intravenous bolus and continuous infusion of 18 IU/Kg/h (n=11)
Number of subjects: 24
Study 11454528 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin - 1 mg/kg/12h subcutaneous (n=13)
Number of subjects: 24
Study 11454528 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (not treated with UFH or enoxaparin)
Number of subjects: 24
Study 11454528 — intervention group
Group type: EXPERIMENTAL
Intervention: UFH and enoxaparin (combined)
Number of subjects: 24
Study 9875837 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen for an additional 5 years
Number of subjects: 1172
Study 9875837 — intervention group
Group type: COMPARATOR
Intervention: Placebo for an additional 5 years
Number of subjects: 1172
Study 7809316 — intervention group
Group type: EXPERIMENTAL
Intervention: Opening-up meditation
Number of subjects: 45
Study 7809316 — intervention group
Group type: COMPARATOR
Intervention: Relaxation
Number of subjects: 45
Study 7809316 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 45
Study 3293399 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 76
Study 3293399 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 29482720 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose piperaquine (LD-PIP)
Number of subjects: 16
Study 29482720 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfadoxine-pyrimethamine (SP)
Number of subjects: 16
Study 29482720 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 16
Study 28483414 — intervention group
Group type: EXPERIMENTAL
Intervention: P2-VP8-P[8] subunit rotavirus vaccine (30 μg)
Number of subjects: 162
Study 28483414 — intervention group
Group type: EXPERIMENTAL
Intervention: P2-VP8-P[8] subunit rotavirus vaccine (60 μg)
Number of subjects: 162
Study 28483414 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 162
Study 28483414 — intervention group
Group type: EXPERIMENTAL
Intervention: P2-VP8-P[8] subunit rotavirus vaccine and Placebo
Number of subjects: 162
Study 26260973 — intervention group
Group type: EXPERIMENTAL
Intervention: VEINES-QOL questionnaire
Number of subjects: 451
Study 26260973 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrinsic scoring method
Number of subjects: 451
Study 24131587 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal arm (Triple P - Positive Parenting Program, level 2)
Number of subjects: 0
Study 24131587 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal Plus arm (Triple P - Positive Parenting Program, level 2, level 3, and level 4 group)
Number of subjects: 0
Study 24131587 — intervention group
Group type: COMPARATOR
Intervention: Services as Usual arm
Number of subjects: 0
Study 24131587 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal arm, Universal Plus arm, Services as Usual arm
Number of subjects: 0
Study 21933908 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensor-augmented pump (SAP) therapy
Number of subjects: 420
Study 21933908 — intervention group
Group type: COMPARATOR
Intervention: Optimized multiple daily injection (MDI) therapy
Number of subjects: 420
Study 20467621 — intervention group
Group type: EXPERIMENTAL
Intervention: Bio‐Oss (anorganic bovine bone blocks)
Number of subjects: 10
Study 20467621 — intervention group
Group type: COMPARATOR
Intervention: Autogenous bone (bone blocks harvested from the iliac crest)
Number of subjects: 10
Study 15367503 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyridostigmine (45 mg)
Number of subjects: 15
Study 15367503 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 11467988 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium phosphate-adsorbed five-grass-pollen extract
Number of subjects: 29
Study 11467988 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 9488270 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery for the largest angle measured
Number of subjects: 90
Study 9488270 — intervention group
Group type: COMPARATOR
Intervention: Surgery for the initial angle measured at 6 m (Control)
Number of subjects: 90
Study 8059699 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil 240 mg once daily
Number of subjects: 20
Study 8059699 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 3046221 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycopyrrolate (10 micrograms.kg‐1)
Number of subjects: 31
Study 3046221 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine (20 micrograms.kg‐1)
Number of subjects: 31
Study 3046221 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 31
Study 29926478 — intervention group
Group type: EXPERIMENTAL
Intervention: MEDI0382 (5 μg, 10 μg, 30 μg, 100 μg, 150 μg, 300 μg)
Number of subjects: 48
Study 29926478 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 26358841 — intervention group
Group type: EXPERIMENTAL
Intervention: OKZ 60 mg/120 mg/240 mg every four weeks (Q4W)
Number of subjects: 119
Study 26358841 — intervention group
Group type: EXPERIMENTAL
Intervention: OKZ 60 mg/120 mg every two weeks (Q2W)
Number of subjects: 119
Study 26358841 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study 24751388 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nalbuphine (5 μg/kg/hour)
Number of subjects: 90
Study 24751388 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nalbuphine (10 μg/kg/hour)
Number of subjects: 90
Study 24751388 — intervention group
Group type: COMPARATOR
Intervention: Control (normal saline)
Number of subjects: 90
Study 24751388 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nalbuphine (5 μg/kg/hour) and (10 μg/kg/hour)
Number of subjects: 90
Study 22520118 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentavalent rotavirus vaccine (PRV)
Number of subjects: 1136
Study 22520118 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1136
Study 20089065 — intervention group
Group type: EXPERIMENTAL
Intervention: 60-min slides lecture by a military dental practitioner
Number of subjects: 336